- Home
- IHRT vs GTHX Comparison
IHRT vs GTHX Comparison
Compare IHRT & GTHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- GTHX
- Stock Information
- Founded
- IHRT N/A
- GTHX 2008
- Country
- IHRT United States
- GTHX United States
- Employees
- IHRT N/A
- GTHX N/A
- Industry
- IHRT Broadcasting
- GTHX Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- GTHX Health Care
- Exchange
- IHRT Nasdaq
- GTHX Nasdaq
- Market Cap
- IHRT 207.1M
- GTHX 375.6M
- IPO Year
- IHRT 2019
- GTHX 2017
- Fundamental
- Price
- IHRT $1.47
- GTHX $7.13
- Analyst Decision
- IHRT Hold
- GTHX Buy
- Analyst Count
- IHRT 5
- GTHX 4
- Target Price
- IHRT $3.00
- GTHX $3.50
- AVG Volume (30 Days)
- IHRT 421.1K
- GTHX 1.7M
- Earning Date
- IHRT 08-08-2024
- GTHX 10-30-2024
- Dividend Yield
- IHRT N/A
- GTHX N/A
- EPS Growth
- IHRT N/A
- GTHX N/A
- EPS
- IHRT N/A
- GTHX N/A
- Revenue
- IHRT $3,747,902,000.00
- GTHX $58,195,000.00
- Revenue This Year
- IHRT $6.56
- GTHX N/A
- Revenue Next Year
- IHRT N/A
- GTHX $28.49
- P/E Ratio
- IHRT N/A
- GTHX N/A
- Revenue Growth
- IHRT N/A
- GTHX N/A
- 52 Week Low
- IHRT $0.81
- GTHX $1.08
- 52 Week High
- IHRT $3.68
- GTHX $7.19
- Technical
- Relative Strength Index (RSI)
- IHRT 49.24
- GTHX 84.72
- Support Level
- IHRT $1.37
- GTHX $7.10
- Resistance Level
- IHRT $1.52
- GTHX $7.19
- Average True Range (ATR)
- IHRT 0.13
- GTHX 0.02
- MACD
- IHRT -0.02
- GTHX -0.13
- Stochastic Oscillator
- IHRT 26.32
- GTHX 45.45
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About GTHX G1 Therapeutics Inc.
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy.